We recently compiled a list of the Billionaire Mason Hawkins’ Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against the other stocks.
Mason Hawkins is a prominent figure in the world of value investing, best known as the founder and chairman of Southeastern Asset Management, an investment firm established in 1975. The firm began with a modest pool of assets but grew to manage approximately $20 billion within a few years. With decades of experience and a reputation for disciplined investment strategies, Hawkins has earned widespread respect among investors and financial professionals for his long-term approach to wealth creation. His firm specializes in managing concentrated portfolios based on in-depth research, fundamental analysis, and a value-oriented philosophy. Hawkins believes that patience and a contrarian mindset are critical to success, often holding onto investments for years to allow their true value to emerge.
Read Also 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According to Goldman Sachs.
This strategy has been central to the success of the flagship Longleaf Partners Funds run by Southeastern Asset Management. For example, during the 20 years leading up to the mid-2000s, the fund achieved an annualized return of approximately 12%, compared to around 10% for the S&P 500. A native of Tennessee, Hawkins graduated from the University of Florida with a degree in Finance and later earned his MBA from the University of Georgia. His early career included roles at Atlantic National Bank and First Tennessee Investment Management before he decided to establish Southeastern Asset Management. Under his leadership, the firm grew from managing a small pool of assets to overseeing billions of dollars across various funds.
One hallmark of the investment style made popular by Hawkins is his emphasis on what he calls a “margin of safety.” This concept, pioneered by Benjamin Graham, involves purchasing stocks at a significant discount to their estimated intrinsic value. By doing so, Hawkins aims to minimize downside risk while maximizing potential returns. This disciplined approach has helped Southeastern Asset Management weather multiple market cycles, including challenging periods like the dot-com bubble and the 2008 financial crisis. Hawkins focuses on quality rather than quantity, reflected in the 13F portfolio of his fund that typically holds positions in twenty to thirty stocks, highlighting a preference for concentration rather than diversification. This approach allows the firm to take significant positions in companies it believes in, leading to outsized returns when these investments succeed.
Read Also 30 Most Important AI Stocks According to BlackRock and Beyond the Tech Giants: 35 Non-Tech AI Opportunities.
For this article, we selected stocks by combing through the 13F portfolio of Southeastern Asset Management at the end of the third quarter of 2024. Only the companies that have been in the 13F portfolio of the fund consistently for the past three years were selected. These stocks are also popular among other hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A close up of a patient and a healthcare professional engaging in conversation, showing the company’s commitment to patient care.
Oscar Health, Inc. (NYSE:OSCR)
Number of Hedge Fund Holders: 45
Oscar Health, Inc. (NYSE:OSCR) is a health insurance provider. The hedge fund’s Q3 2024 filing revealed ownership of 2 million shares in Oscar Health, Inc. (NYSE:OSCR), valued at over $43 million and comprising 2.05% of its 13F portfolio. Promising financial performance records, technological innovation, and strategic market expansion are some of the stand-away features that make the firm a great platform to invest in. For instance, as per the third quarter report of 2024, the total revenue reported was $2.4 billion, a 68% increase year-over-year, driven by high membership and rate increases. Moreover, an improved medical loss ratio is another factor making Oscar Health worth investing in, as the company achieved an MLR of 84.6% in the third quarter of 2024. This highlights an improvement of 80 basis points as compared to 2023, which demonstrates the company’s efficiency in managing the costs of healthcare. Moreover, projects like +Oscar, a tech-driven platform that extends its proprietary technology stack to third-party payers and providers, show the firm is keeping pace with tech innovations.
Overall OSCR ranks 10th on our list of Billionaire Mason Hawkins’ top long-term stock picks. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Most Important AI Stocks According to BlackRock
Disclosure: None. This article is originally published at Insider Monkey.